<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Of 210 patients with <z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">thyrotoxicosis</z:e>, 21 (10%) had <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Five of these patients (24%) had systemic emboli (which were multiple in three patients, one of whom died) and two other patients had <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Embolic disease is common in thyrotoxic <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy should be considered for <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
</text></document>